STONY BROOK, NY--(Marketwired - December 04, 2014) - Applied DNA Sciences, Inc. (NASDAQ: APDN) (Twitter: @APDN), a provider of DNA-based anti-counterfeiting technology and product authentication, will participate in two investor conferences on Thursday, December 11. Company management will discuss the Company's botanical-DNA based security and authentication solutions and services.

Dr. James A. Hayward, President and CEO, will be presenting at 2:30 PM ET in the Metropolitan West Room at the Imperial Capital Security Investor Conference, being held at the Waldorf Astoria New York in New York City. Both Dr. Hayward and Karol Kain Gray, Chief Financial Officer, will be in attendance at scheduled one-to-one meetings. 

Additionally Janice Meraglia, Vice President, Government & Military Programs, and Mitchell Miller, Director, Communications, will participate in the Benchmark Micro Cap Discovery One-on-One Conference at The Palmer House Hilton in Chicago, Illinois, and will be available for one-on-one meetings with investors between 8:00 am and 2:30 pm CT. Investors interested in scheduling a meeting with Ms. Meraglia or Mr. Miller should contact Vince Curatola, Director of Corporate Access at The Benchmark Company, at 1-414-203-5556 or 1-877-242-1759.

The Imperial Capital Security Investor Conference is the security industry's leading conference that brings together a select group of companies to present their positioning and strategic growth plans to an audience of key investors and business leaders. Attendees will have the opportunity to listen to, and network with, the leaders of companies delivering the latest compelling security solutions across the Enterprise, Residential and Homeland Security markets. For more information, please visit:

The Benchmark Micro Cap Discovery One-on-One Conference is produced by The Benchmark Company, LLC to showcase dynamic, publicly traded micro cap companies in an intimate conference setting. For more information, please visit:

About Applied DNA Sciences

Applied DNA Sciences (APDN) is a provider of botanical-DNA based security and authentication solutions and services that can help protect products, brands, entire supply chains, and intellectual property of companies, governments and consumers from theft, counterfeiting, fraud and diversion. SigNature® DNA describes the uncopyable marker that is at the heart of all of our security and authentication solutions. SigNature DNA is at the core of a family of products such as DNAnet®, our anti-theft product, SigNature® T, targeted toward textiles, and digitalDNA®, providing powerful track and trace. All provide a forensic chain of evidence and can be used to prosecute perpetrators.

Forward Looking Statements

The statements made by Applied DNA Sciences may be forward-looking in nature. Forward-looking statements describe APDN's future plans, projections, strategies and expectations, and are based on assumptions and involve a number of risks and uncertainties, many of which are beyond the control of APDN. Actual results could differ materially from those projected due to our short operating history, limited financial resources, limited market acceptance, market competition and various other factors detailed from time to time in Applied DNA Sciences' SEC reports and filings, including our Annual Report on Form 10-K filed on December 20, 2013 (amended on May 1, 2014) and our subsequent quarterly reports on Form 10-Q/A (for the quarterly period ended December 31, 2013) and Form 10-Q for the quarterly periods ended March 31, 2014 and June 30, 2014. APDN undertakes no obligation to update publicly any forward-looking statements to reflect new information, events or circumstances after the date hereof to reflect the occurrence of unanticipated events.

Contact Information:

Media Contact:
Mitchell Miller

Investor Contact:
Debbie Bailey


@APDN, @APDNInvestor